FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2296274219> ?p ?o ?g. }

• W2296274219 endingPage "718" @default.
• W2296274219 startingPage "712" @default.
• W2296274219 abstract "Introduction. The risk of metabolic abnormalities is greatly increased in schizophrenic patients started on an atypical antipsychotic medication. Patients with psychiatric disorders exceed mortality ranges resulting from, among others, increased risk of cardiovascular events. Other factors contributing to the development of metabolic syndrome include prolonged duration of illness, increasing age, female sex and lifestyle factors. Objective. This cross-sectional study was taken up to assess the prevalence of the metabolic syndrome (MetS) in schizophrenic patients receiving olanzapine monotherapy for at least six months and to determine the most important risk factors associated with metabolic syndrome presence in these patients. Methods. A total of 93 long term hospitalized schizophrenic patients (71 men, 22 women), had a screening of the following: case-history data, psychiatric scales, anthropometric measures, blood (fasting glucose, lipid status, C-reactive protein - CRP) and urine samples (microalbuminuria). Results. Prevalence of MetS according to International Diabetes Federation criteria in our study was 34.4%. The multivariate analysis distinguished the following significant predictors of MetS presence (in order of appearance): data about diabetes mellitus in family history (p=0.002), body mass index >25 kg/m2 (p=0.002), hyperlipidemia in family history (p=0.008), and elevated CRP value (p=0.042). Conclusion. High rate of MetS in patients treated with olanzapine in this study exceeds MetS prevalence in general population. Among observed parameters, our study pointed to several ?high risk? predictors associated with MetS presence. Regular monitoring of cardiometabolic risk factors is highly recommended. Positive heredity distress mentioned above may direct a psychiatrist to prescribe some other drug than olanzapine in the long term treatment of schizophrenia." @default.
• W2296274219 created "2016-06-24" @default.
• W2296274219 creator A5002293200 @default.
• W2296274219 creator A5014694889 @default.
• W2296274219 creator A5017983497 @default.
• W2296274219 creator A5018410181 @default.
• W2296274219 creator A5038976595 @default.
• W2296274219 creator A5048804994 @default.
• W2296274219 creator A5062686313 @default.
• W2296274219 creator A5074295329 @default.
• W2296274219 date "2015-01-01" @default.
• W2296274219 modified "2023-09-27" @default.
• W2296274219 title "Long-term treatment with olanzapine in hospital conditions: Prevalence and predictors of the metabolic syndrome" @default.
• W2296274219 cites W1565350250 @default.
• W2296274219 cites W167785250 @default.
• W2296274219 cites W1799577887 @default.
• W2296274219 cites W1976750423 @default.
• W2296274219 cites W1983408983 @default.
• W2296274219 cites W1985517071 @default.
• W2296274219 cites W1995249085 @default.
• W2296274219 cites W1998128856 @default.
• W2296274219 cites W2000767861 @default.
• W2296274219 cites W2016716999 @default.
• W2296274219 cites W2020844317 @default.
• W2296274219 cites W2036740944 @default.
• W2296274219 cites W2054728525 @default.
• W2296274219 cites W2058296375 @default.
• W2296274219 cites W2062359581 @default.
• W2296274219 cites W2074289679 @default.
• W2296274219 cites W2079515918 @default.
• W2296274219 cites W2080502457 @default.
• W2296274219 cites W2107732097 @default.
• W2296274219 cites W2112273817 @default.
• W2296274219 cites W2116960204 @default.
• W2296274219 cites W2126642792 @default.
• W2296274219 cites W2130717716 @default.
• W2296274219 cites W2136165753 @default.
• W2296274219 cites W2149992443 @default.
• W2296274219 cites W2152770536 @default.
• W2296274219 cites W2155408563 @default.
• W2296274219 cites W2159793865 @default.
• W2296274219 cites W2168991266 @default.
• W2296274219 cites W2169055778 @default.
• W2296274219 doi "https://doi.org/10.2298/sarh1512712p" @default.
• W2296274219 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26946767" @default.
• W2296274219 hasPublicationYear "2015" @default.
• W2296274219 type Work @default.
• W2296274219 sameAs 2296274219 @default.
• W2296274219 citedByCount "8" @default.
• W2296274219 countsByYear W22962742192017 @default.
• W2296274219 countsByYear W22962742192018 @default.
• W2296274219 countsByYear W22962742192021 @default.
• W2296274219 crossrefType "journal-article" @default.
• W2296274219 hasAuthorship W2296274219A5002293200 @default.
• W2296274219 hasAuthorship W2296274219A5014694889 @default.
• W2296274219 hasAuthorship W2296274219A5017983497 @default.
• W2296274219 hasAuthorship W2296274219A5018410181 @default.
• W2296274219 hasAuthorship W2296274219A5038976595 @default.
• W2296274219 hasAuthorship W2296274219A5048804994 @default.
• W2296274219 hasAuthorship W2296274219A5062686313 @default.
• W2296274219 hasAuthorship W2296274219A5074295329 @default.
• W2296274219 hasBestOaLocation W22962742191 @default.
• W2296274219 hasConcept C118552586 @default.
• W2296274219 hasConcept C126322002 @default.
• W2296274219 hasConcept C134018914 @default.
• W2296274219 hasConcept C2776412080 @default.
• W2296274219 hasConcept C2776619155 @default.
• W2296274219 hasConcept C2779091943 @default.
• W2296274219 hasConcept C2780221984 @default.
• W2296274219 hasConcept C2780494398 @default.
• W2296274219 hasConcept C2780578515 @default.
• W2296274219 hasConcept C2781179581 @default.
• W2296274219 hasConcept C2781203188 @default.
• W2296274219 hasConcept C2908647359 @default.
• W2296274219 hasConcept C555293320 @default.
• W2296274219 hasConcept C71924100 @default.
• W2296274219 hasConcept C84393581 @default.
• W2296274219 hasConcept C99454951 @default.
• W2296274219 hasConceptScore W2296274219C118552586 @default.
• W2296274219 hasConceptScore W2296274219C126322002 @default.
• W2296274219 hasConceptScore W2296274219C134018914 @default.
• W2296274219 hasConceptScore W2296274219C2776412080 @default.
• W2296274219 hasConceptScore W2296274219C2776619155 @default.
• W2296274219 hasConceptScore W2296274219C2779091943 @default.
• W2296274219 hasConceptScore W2296274219C2780221984 @default.
• W2296274219 hasConceptScore W2296274219C2780494398 @default.
• W2296274219 hasConceptScore W2296274219C2780578515 @default.
• W2296274219 hasConceptScore W2296274219C2781179581 @default.
• W2296274219 hasConceptScore W2296274219C2781203188 @default.
• W2296274219 hasConceptScore W2296274219C2908647359 @default.
• W2296274219 hasConceptScore W2296274219C555293320 @default.
• W2296274219 hasConceptScore W2296274219C71924100 @default.
• W2296274219 hasConceptScore W2296274219C84393581 @default.
• W2296274219 hasConceptScore W2296274219C99454951 @default.
• W2296274219 hasIssue "11-12" @default.
• W2296274219 hasLocation W22962742191 @default.
• W2296274219 hasLocation W22962742192 @default.
• W2296274219 hasOpenAccess W2296274219 @default.

• next